Macrogen delivers comprehensive access to human genomic variation through high-depth whole genome sequencing (WGS), powered by the latest-generation platforms offering ultra-long reads, exceptional accuracy, and uniform coverage across the genome.
Our WGS service is optimised for a wide range of applications — from cancer genomics and tumour/normal comparative studies (for detection of SNPs, CNVs, and structural variants) to population-scale genomics, pharmacogenomics, and analysis of inherited diseases, including rare and complex conditions. Both high- and low-depth options are available to suit your research goals.
With an annual capacity exceeding 500,000 whole genomes or equivalent, Macrogen is equipped to support projects of any size — from small pilot studies to large, multi-centre cohorts. Despite the complexity of large-scale sequencing, our standard turnaround time remains 4 to 6 weeks, ensuring efficient project delivery without compromising data quality.
